JBM (Healthcare) (HKSE:02161) FCF Margin % : 31.04% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is JBM (Healthcare) FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. JBM (Healthcare)'s Free Cash Flow for the six months ended in Sep. 2024 was HK$123.9 Mil. JBM (Healthcare)'s Revenue for the six months ended in Sep. 2024 was HK$399.0 Mil. Therefore, JBM (Healthcare)'s FCF Margin % for the quarter that ended in Sep. 2024 was 31.04%.

As of today, JBM (Healthcare)'s current FCF Yield % is 11.46%.

The historical rank and industry rank for JBM (Healthcare)'s FCF Margin % or its related term are showing as below:

HKSE:02161' s FCF Margin % Range Over the Past 10 Years
Min: 8.85 Med: 15.54 Max: 27.91
Current: 35.3

During the past 7 years, the highest FCF Margin % of JBM (Healthcare) was 27.91%. The lowest was 8.85%. And the median was 15.54%.

HKSE:02161's FCF Margin % is ranked better than
97.89% of 993 companies
in the Drug Manufacturers industry
Industry Median: 0.89 vs HKSE:02161: 35.30

JBM (Healthcare) FCF Margin % Historical Data

The historical data trend for JBM (Healthcare)'s FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JBM (Healthcare) FCF Margin % Chart

JBM (Healthcare) Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

8.85

9.01

13.03

26.42

27.91

JBM (Healthcare) Semi-Annual Data
	Mar18	Mar19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
FCF Margin %	Get a 7-Day Free Trial							24.39	28.12	15.44	40.59	31.04

Competitive Comparison of JBM (Healthcare)'s FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, JBM (Healthcare)'s FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JBM (Healthcare)'s FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JBM (Healthcare)'s FCF Margin % distribution charts can be found below:

* The bar in red indicates where JBM (Healthcare)'s FCF Margin % falls into.

JBM (Healthcare) FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

JBM (Healthcare)'s FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	181.002	/	648.415
	=	27.91 %

JBM (Healthcare)'s FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	123.854	/	398.953
	=	31.04 %

JBM (Healthcare) FCF Margin % Related Terms

Thank you for viewing the detailed overview of JBM (Healthcare)'s FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

JBM (Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JBM (Healthcare) Ltd (HKSE:02161) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

108 Wai Yip Street, Units 808-811, 8 floor, C-Bons International Centre, Kwun Tong, Kowloon, Hong Kong, HKG

Website

https://www.jbmhealthcare.com.hk

JBM (Healthcare) Ltd markets and distributes healthcare products. The company's operating segment includes Branded medicines; Proprietary Chinese medicines and Health and wellness products. It generates maximum revenue from the Proprietary Chinese medicines segment. The Proprietary Chinese medicines segment develops, manufactures, and distributes registered Chinese medicines composed solely of any Chinese herbal medicines specified in the Chinese Medicine Ordinance, or any materials of herbal, animal, or mineral origin customarily or widely used by the Chinese. Geographically, it derives a majority of its revenue from Hong Kong.

Executives

Ubs Trustees (b.v.i.) Limited
Kingshill Development Group Inc
Sum Kwong Yip, Derek
Queenshill Development Limited
Lincoln's Hill Development Limited
Yun Nan Bai Yao Ji Tuan Gu Fen You Xian Gong Si
New Heritage Healthcare Limited	2101 Beneficial owner
Gavett Limited	2201 Interest of corporation controlled by you
United Islands Group Limited	2201 Interest of corporation controlled by you
Fortstar Limited	2201 Interest of corporation controlled by you
Tao Richard	2201 Interest of corporation controlled by you
Hon Hing Tong Patricia	2202 Interest of your spouse
Tao Paul	2201 Interest of corporation controlled by you
Choi Siu Ping	2202 Interest of your spouse
Longjin Investments Limited	2101 Beneficial owner

JBM (Healthcare) Headlines

No Headlines